Granules India Ltd

GRANULES
Health CarePharmaceuticals
SmallcapWith a market cap of ₹7,982 cr, stock is ranked 407
Moderate RiskStock is 2.41x as volatile as Nifty
321.854.55 (+1.43%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹7,982 cr, stock is ranked 407
Moderate RiskStock is 2.41x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
14.53
PB RatioPB Ratio
3.67
Dividend YieldDiv. Yield
0.47%
Sector PESector PE
37.99
Sector PBSector PB
5.06
Sector Div YldSctr Div Yld
0.68%

Forecast & RatingsDetailed Forecast 

43%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Granules India Limited is a pharmaceutical company that manufactures finished dosages (FDs), pharmaceutical formulation intermediates (PFIs) and active pharmaceutical ingredients (APIs).

Investor PresentationView older 

Nov 12, 2021

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

20182019202020211.712.352.693.260.130.240.340.55
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Increased Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has increased by 1.57%

See detailed holdings

Recent EventsAll events 

Outcome of Board Meeting 
Announced OnJan 3, 2022

Granules India Limited has informed the Exchange regarding Board meeting held on January 03, 2022. | Download

Granules India Limited has informed the Exchange regarding Board meeting held on January 03, 2022. | Download

Press Release 
Announced OnDec 30, 2021

Granules India Limited has informed the Exchange regarding a press release dated December 30, 2021, titled "Granules Pharmaceuticals, Inc. receives ANDA approval for Amphetamine Mixed Salts (IR Tablets)". | Download

Granules India Limited has informed the Exchange regarding a press release dated December 30, 2021, titled "Granules Pharmaceuticals, Inc. receives ANDA approval for Amphetamine Mixed Salts (IR Tablets)". | Download

Cash Dividend 
Ex. DateNov 24, 2021

Interim 2 • Div/Share: ₹ 0.25

See all events